| Epothilone B |
ENSG00000088970.11 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000124835.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000124835.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000126005.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000132204.9 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000132832.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000146666.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000163597.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000172965.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000174365.15 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000175147.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000175611.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000175701.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000177112.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000177337.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000177822.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000177822.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000177993.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000178193.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000178440.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000178803.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000179859.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000181097.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000181097.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000182057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000182165.13 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000182376.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000182404.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000182586.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000182648.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000184274.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000184274.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000184324.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000185837.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000185847.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000186594.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000186594.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000188424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000188825.9 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000189238.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000189419.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000197210.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000197291.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000197463.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000197934.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000197934.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000198106.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000198221.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000203327.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000203441.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000203497.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000203499.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000203875.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000204011.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000204055.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000204241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000204758.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000204934.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000205015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000205037.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000205488.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000205628.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000205662.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000205663.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000205890.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000206113.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000206142.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000206176.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000212163.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000212694.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000213468.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000213742.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000213793.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000213971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000214184.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000214353.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000214407.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000214803.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000214922.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000215190.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000215244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000215394.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000215424.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000215424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000215498.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000222043.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000223356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223379.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000223401.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000223442.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000223477.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000223477.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000223478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223478.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000223485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223522.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000223522.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000223528.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000223552.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000223579.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000223653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000223660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000223685.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000223685.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000223692.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000223695.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000223715.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000223725.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223749.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000223779.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000223791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223839.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000223839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000223935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000223949.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000224031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224057.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000224157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000224216.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000224269.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000224276.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000224281.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000224349.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224363.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000224409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000224413.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224424.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000224490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000224505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000224541.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000224621.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000224635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000224660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000224660.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000224687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000224698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224699.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000224738.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000224794.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000224812.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000224814.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000224844.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000224857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000224875.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000224884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000224884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000224933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000224945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000224945.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000224992.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000225057.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000225092.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000225096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225113.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000225205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225205.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000225210.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225210.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000225218.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225255.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000225284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000225353.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000225408.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000225411.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000225439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225439.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000225439.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000225511.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225527.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000225555.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000225643.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000225762.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000225778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000225791.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225839.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000225850.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000225930.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000225931.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000225937.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000225956.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000226149.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000226149.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000226167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000226179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226266.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000226287.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000226287.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226310.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000226332.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000226334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226377.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000226380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000226381.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000226381.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000226455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226465.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000226465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000226578.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000226598.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226622.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000226643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000226684.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000226738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000226833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000226853.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000226862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226869.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000226889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000226889.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000226904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227028.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000227053.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227076.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000227107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227155.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000227220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000227285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000227308.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000227388.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000227403.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000227477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227477.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000227502.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000227603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227603.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000227627.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000227646.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227695.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000227698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000227740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000227844.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000227857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000227896.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000227946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000227959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000227959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000227959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000227963.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000228013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228016.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000228065.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000228079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000228140.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000228172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228192.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000228192.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000228201.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000228242.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000228251.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000228274.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000228294.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228313.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000228317.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000228322.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000228323.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000228340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000228340.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000228393.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000228436.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000228470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000228481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228506.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000228509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228560.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000228624.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228634.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000228682.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000228718.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000228723.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228817.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000228877.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000228878.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000229043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229043.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000229056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000229111.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000229122.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000229124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000229190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000229263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000229267.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000229278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000229291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000229401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000229521.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000229645.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000229666.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000229697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000229766.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000229780.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000229801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229839.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000229852.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000229852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000229867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229970.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000229980.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000229999.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000230013.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000230068.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000230068.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000230091.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000230124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230124.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230124.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000230155.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230303.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230303.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000230310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230513.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000230513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000230534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000230539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230587.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000230612.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000230658.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000230699.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000230731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000230825.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000230825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000230836.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000230914.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000230925.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000231010.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000231073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000231104.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231119.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000231172.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231196.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000231290.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000231298.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000231298.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231305.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000231367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000231460.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000231566.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000231611.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000231628.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000231636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231636.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000231636.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000231651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231652.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231711.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000231734.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000231734.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000231742.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000231760.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231770.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000231795.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000231851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000231856.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000231948.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000231948.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000231966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000231977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000231999.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000232028.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000232031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000232034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000232046.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232077.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000232116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000232117.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000232259.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000232406.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000232412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000232415.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000232470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232485.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000232490.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000232504.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232527.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000232527.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000232545.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000232564.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000232586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232613.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000232648.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000232656.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232677.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000232684.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000232692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232710.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000232721.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000232725.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000232729.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000232732.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000232762.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232876.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000232912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000232931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000232973.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000232977.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000232987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000232995.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000233002.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000233056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233056.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233215.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000233220.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000233237.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000233250.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000233330.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000233330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000233330.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000233351.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000233368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233554.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000233621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000233654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000233661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233684.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233723.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233776.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000233783.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000233785.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000233791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233797.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000233806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233845.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000233901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000233912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000234019.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000234174.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000234185.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000234206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234208.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234232.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234252.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000234255.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234380.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000234390.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000234393.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234428.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000234449.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000234584.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000234626.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234690.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000234695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000234705.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234807.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234883.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234902.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000234917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000234962.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000234978.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000235005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000235027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235072.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000235106.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000235117.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000235138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235138.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000235180.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000235214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000235319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000235335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235481.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235560.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235590.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000235609.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000235641.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235724.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000235770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000235781.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000235790.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235872.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000235890.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000235904.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236017.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000236051.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000236064.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000236088.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000236091.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000236095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000236107.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236107.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236115.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000236137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000236140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000236144.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236197.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236200.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000236204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000236209.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000236213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236256.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000236266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236299.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000236318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236347.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000236364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236404.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000236545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236558.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000236591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236671.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000236703.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236717.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000236772.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000236799.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000236810.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000236824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000236889.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000236908.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000236936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000236986.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000236991.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237188.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000237200.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000237250.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000237253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000237424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000237438.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000237461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237502.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237505.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000237517.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000237520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000237560.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000237646.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000237658.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000237689.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000237697.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000237697.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000237714.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000237862.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237892.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000237899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000237914.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000237934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000237976.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000237998.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000238062.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000238107.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000238107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000238113.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000238122.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000238133.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000238140.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000238164.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000238184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000238197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000238198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000238198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000238273.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000238280.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000238287.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000238287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000238290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000238290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000239002.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000239353.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000239377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000239415.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000239480.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000239552.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000239552.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000240057.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000240207.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000240211.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000240254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000240291.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000240373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000240440.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000240497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000240553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000240790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000240907.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000240990.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000241125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000241180.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000241280.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000241593.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000241593.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000241684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000241720.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000241884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000241933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000242391.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000242396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000242474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000242553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000242687.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000243069.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000243083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000243176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000243179.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000243319.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000243479.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000243701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000243810.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000243885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000243902.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000243967.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000244124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000244128.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000244161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000244252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000244265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000244268.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000244332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000244459.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000244578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000244586.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000244649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000244926.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000245060.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000245146.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000245248.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000245468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000245479.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000245532.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000245534.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000245571.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000245729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000245748.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000245750.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000245750.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000245869.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000245975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000246090.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000246090.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000246228.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000246263.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000246323.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000246422.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000246523.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000246582.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000246763.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000246792.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000247092.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000247095.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000247095.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000247134.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000247311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000247363.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000247373.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000247400.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000247624.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000247679.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000247679.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000247809.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000247877.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000247970.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000247970.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000248079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000248161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000248187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000248275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000248318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000248416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000248429.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000248544.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000248599.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000248668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000248774.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000248779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000248866.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000248890.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000248896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000248980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000249306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000249307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000249310.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000249345.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000249356.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000249395.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000249487.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000249509.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000249584.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000249599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000249628.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000249849.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000249868.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000249894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000249916.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000250027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000250033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000250103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000250222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000250240.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000250413.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000250451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000250548.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000250602.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000250604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000250742.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000250770.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000250846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000250957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000250988.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000250990.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000251072.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251136.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000251144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251161.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000251194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251273.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000251273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000251292.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251298.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000251307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000251314.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000251324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000251350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251396.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000251432.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000251442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251532.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000251536.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000251574.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000251580.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000251602.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251602.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000251675.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000251680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000253106.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000253121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000253161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000253174.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000253263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000253298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000253395.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000253399.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000253420.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000253508.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000253513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000253530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000253552.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000253557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000253567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000253582.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000253603.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000253636.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000253641.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000253695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000253702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000253706.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000253708.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000253741.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000253744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000253796.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000253829.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000253875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000253893.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000253911.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000253917.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000253931.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000253986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000254027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000254044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000254141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000254154.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000254219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000254238.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000254248.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254295.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000254295.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000254339.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000254363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254431.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000254433.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000254450.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000254458.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000254480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000254486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254510.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000254554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000254574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000254577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000254592.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000254606.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000254615.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000254653.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000254671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000254814.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000254869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000254973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000254990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000255027.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255050.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000255050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000255052.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000255119.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000255129.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000255145.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000255164.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000255165.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000255182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255227.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000255247.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000255276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255310.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000255337.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000255343.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000255348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000255348.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000255366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255421.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000255443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255462.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000255474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255503.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000255723.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255850.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000255866.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000255886.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000255946.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000255946.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000255966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000255983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000255989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000256050.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256124.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000256128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256196.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000256250.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000256299.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000256325.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000256427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000256448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256458.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000256481.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000256588.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256615.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000256705.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256712.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000256751.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000256757.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000256897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000256967.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000256973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257221.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000257270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257279.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000257285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257298.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000257298.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000257433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000257475.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000257475.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000257496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000257499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257526.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000257534.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000257556.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000257568.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000257621.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000257696.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000257698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000257698.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000257732.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000257808.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000257890.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000257891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000257894.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000257925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000257931.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000257964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000258044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000258057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258077.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258088.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000258136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258240.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000258260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000258301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000258323.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258325.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000258342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000258378.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000258400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000258413.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000258443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258471.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000258486.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000258490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258517.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258521.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258558.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000258620.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000258623.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000258682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258731.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000258731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000258733.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000258748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258810.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000258821.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000258825.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000258857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000258858.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000258891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258904.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258935.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000258942.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258957.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000258959.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000258982.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000259006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000259023.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259031.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000259058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000259116.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259118.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259134.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259146.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259163.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000259166.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259172.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000259175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000259212.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000259212.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000259245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259274.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000259294.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000259298.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000259327.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000259341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259376.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000259376.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000259402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259416.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000259422.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000259438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259439.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259453.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000259457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259527.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259551.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000259604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259606.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000259617.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000259618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000259652.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000259687.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000259705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000259715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259732.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000259758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000259774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259782.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000259783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000259788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000259792.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000259797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259799.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000259802.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000259802.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000259804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259804.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000259804.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259820.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259865.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000259877.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000259891.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000259894.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260017.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000260025.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000260091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260101.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260156.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260176.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000260177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000260196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260228.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260277.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000260278.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000260285.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000260306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260352.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000260360.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260360.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260368.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260404.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260411.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000260436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260447.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000260470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260470.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260515.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000260578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260579.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260585.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000260588.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000260591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260608.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000260625.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260641.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260664.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260671.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000260698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000260706.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000260708.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000260742.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000260757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260773.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260816.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260841.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260868.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260871.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000260871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260874.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260896.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000260905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260907.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260924.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000260936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000260944.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000260949.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000260973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000260973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000260973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000260978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000260989.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000261039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261040.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000261064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000261064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000261069.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000261122.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000261124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261126.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000261126.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261131.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000261186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261187.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000261188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000261216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261238.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000261252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000261253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261341.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261379.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000261399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261455.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000261471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000261476.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000261488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000261512.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000261512.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000261542.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000261595.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000261600.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261613.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000261632.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000261662.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000261690.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000261693.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000261731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261737.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000261744.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000261760.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261775.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000261798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000261798.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000261799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000261971.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000262001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262094.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262171.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262185.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000262202.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262339.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000262372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262454.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000262521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262580.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262678.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262772.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000262810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000262837.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000262873.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000262877.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000262903.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000262951.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263327.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000263345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000263388.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000263388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000263499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263531.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000263551.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000263603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263612.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000263618.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000263680.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000263753.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000263924.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000263938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000264125.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000264207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000264222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000264222.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000264270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000264270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000264304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264304.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000264513.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000264569.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000264647.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000264829.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264885.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000264895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000264940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000264940.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000264940.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000265010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000265185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000265334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000265399.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000265458.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000265496.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000265688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000265787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000265800.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000266010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000266040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266261.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000266278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000266371.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000266397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000266401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000266411.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000266498.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000266654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000266718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266783.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000266801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000266821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000266835.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000266897.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000266918.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000266947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000266975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000266983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000266993.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000266994.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267018.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000267058.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267064.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000267067.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267073.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000267104.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000267108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000267141.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267150.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000267152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267163.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000267167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267183.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267191.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000267198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267199.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000267219.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267231.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267246.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267272.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000267273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267277.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267289.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267316.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000267342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267375.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000267381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267416.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267470.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000267475.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000267493.2 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267502.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000267505.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000267505.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267546.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267551.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267565.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267605.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000267613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267626.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000267637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267649.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000267658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000267737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000267871.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000267922.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000267927.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000267927.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000268015.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000268027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000268093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000268199.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000268199.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000268205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000268333.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000268355.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000268366.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000268458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268518.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000268530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000268544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000268564.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268613.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000268649.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268707.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000268707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000268743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000268764.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000268764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000268812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000268945.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000269051.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000269102.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000269107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000269161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000269202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269246.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000269246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000269352.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000269365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000269444.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269481.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000269600.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000269652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269653.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000269694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269900.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000269903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000269918.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000269921.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000269923.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000269925.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000269925.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269961.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000269974.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000269974.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000269976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269979.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000269983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000269997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000270006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000270010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270019.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000270031.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000270031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000270036.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000270039.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000270041.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000270048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000270081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270091.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000270100.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000270100.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000270102.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000270104.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000270115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270127.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270141.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000270145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000270157.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000270157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000270173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000270457.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000270562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270659.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000270828.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000270876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000270949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000271133.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000271147.3 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000271172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000271204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271270.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000271270.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271398.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000271427.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000271551.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000271553.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000271646.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000271709.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000271737.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000271751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000271778.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000271781.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000271788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271815.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000271826.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271835.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000271843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000271857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271888.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000271888.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000271912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000271912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000271943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000271948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000271973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000271975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000271975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000271991.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000271998.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272024.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272029.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272030.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000272033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272043.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000272048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272048.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000272071.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272112.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272142.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272146.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272148.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000272180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000272183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272209.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000272217.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272338.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000272342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272370.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272417.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000272438.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000272446.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272482.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272529.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272529.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000272529.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272558.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272574.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272583.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000272604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000272622.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272639.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272650.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000272660.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272663.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000272695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000272709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272716.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272719.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000272720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272732.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272760.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000272761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000272795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272800.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000272836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272861.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000272861.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Epothilone B |
ENSG00000272862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272871.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000272872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272872.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000272888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272904.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000272917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000272977.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000272983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000273014.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273038.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000273056.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000273058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000273073.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273084.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273091.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000273096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273097.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000273108.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000273125.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000273131.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273142.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000273174.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000273181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000273186.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Epothilone B |
ENSG00000273186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273218.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273237.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000273240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273253.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000273264.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Epothilone B |
ENSG00000273270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000273271.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000273272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273281.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000273308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000273338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000273342.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000273342.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Epothilone B |
ENSG00000273343.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Epothilone B |
ENSG00000273366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Epothilone B |
ENSG00000273374.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Epothilone B |
ENSG00000273384.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273384.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Epothilone B |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273403.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273432.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Epothilone B |
ENSG00000273437.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Epothilone B |
ENSG00000273447.1 |
Predicted lncRNA |
Sarcoma |
|
| Epothilone B |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
ENSG00000273451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273451.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Epothilone B |
ENSG00000273454.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Epothilone B |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Epothilone B |
miR-200c |
Curated miRNA |
endometrial cancer |
|
